Loading…

Career Consensus: 2016 Employment Survey

While the pending exit of the United Kingdom from the European Union has generated uncertainty for industries and employees, including the bio/pharma markets across Europe, bio/pharma employees also expressed concerns about compensation, job security, and career development in the 2016 Pharmaceutica...

Full description

Saved in:
Bibliographic Details
Published in:Pharmaceutical technology Europe 2016-12, Vol.28 (12), p.14
Main Author: Peters, Rita C
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:While the pending exit of the United Kingdom from the European Union has generated uncertainty for industries and employees, including the bio/pharma markets across Europe, bio/pharma employees also expressed concerns about compensation, job security, and career development in the 2016 Pharmaceutical Technology/Pharmaceutical Technology Europe annual employment survey (1). The respondents had a range of experience in the bio/pharma industry; approximately onequarter had fewer than 10 years of experience, one-third had 10-20 years, and one-third had 20-35 years of experience, and approximately 7% have worked in the industry for more than 35 years. workloads continue to rise While reported workloads remained stable or decreased slightly compared to recent years, most respondents are working more hours than they are contractually obligated.
ISSN:1753-7967